Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 23, 2017 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )
ClinicalTrials.gov Identifier:
NCT00942877
First received: July 18, 2009
Last updated: April 20, 2017
Last verified: February 23, 2017